What does Sutro Biopharma, Inc. do?

Jun 22 2025 06:47 PM IST
share
Share Via
Sutro Biopharma, Inc. is a clinical stage company focused on developing protein therapeutics for cancer and autoimmune disorders. As of March 2025, it reported net sales of $17 million and a net loss of $76 million, with a market cap of $66.73 million.
Overview:
Sutro Biopharma, Inc. is a clinical stage drug discovery, development, and manufacturing company focused on creating protein therapeutics for cancer and autoimmune disorders within the Pharmaceuticals & Biotechnology industry. Financial Snapshot: Most recent Net Sales: 17 Million (Quarterly Results - Mar 2025) Most recent Net Profit: -76 Million (Quarterly Results - Mar 2025) Market cap: USD 66.73 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 0.00% Debt Equity: 1.97 Return on Equity: 887.14% Price to Book: -2.59 Contact Details: Address: 310 Utah Ave Ste 150, SOUTH SAN FRANCISCO CA: 94080-6803 Tel: 1 650 3928412 Fax: 1 302 6555049 Website: http://www.sutrobio.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Sutro Biopharma, Inc. technically bullish or bearish?
Sep 20 2025 07:49 PM IST
share
Share Via
Is Sutro Biopharma, Inc. overvalued or undervalued?
Sep 20 2025 06:24 PM IST
share
Share Via
Is Sutro Biopharma, Inc. overvalued or undervalued?
Jun 25 2025 09:03 AM IST
share
Share Via
Is Sutro Biopharma, Inc. technically bullish or bearish?
Jun 25 2025 08:51 AM IST
share
Share Via
Who are in the management team of Sutro Biopharma, Inc.?
Jun 22 2025 10:34 PM IST
share
Share Via
How big is Sutro Biopharma, Inc.?
Jun 22 2025 06:04 PM IST
share
Share Via